Tag: life sciences
-
$300M Fund to Back European Life Science Companies
A new investment fund plans to invest $300 million in European life science and biotechnology companies in the later stages of their product development.
-
First Agricultural Crispr Products Expected by 2020
While the genome editing technique known as Crispr is generating discussion in the health field, its first commercial applications are likely to be in agriculture.
-
3-D Printed Patch Helps Grow New Blood Vessels
A biomedical engineering team developed a printed patch infused with cells that in lab animals grows new blood vessels to counteract blocked or hardened arteries.
-
Brain-Computer Device Tested with Consciousness Patients
Tests of a device designed for people with consciousness disorders to provide basic feedback to questions show the system can elicit and capture responses from these individuals.
-
Supreme Court Cuts Biosimilar Waiting Time
The U.S. Supreme Court ruled yesterday that makers of biologic drugs similar to branded originals need not wait an additional 6 months to begin marketing their products.
-
Institutions to Apply AI Models to Type 1 Diabetes
A children’s hospital and diabetes research center are evaluating techniques using artificial intelligence to better identify and manage the care of people with type 1 diabetes.
-
Cancer Center to Test Focused Radiation Therapy
MD Anderson Cancer Center is testing new radiation treatments for cancer designed to reduce adverse side effects of conventional radiation therapy.
-
Pharma Company Seeking Digital Tech Partners
Drug maker AstraZeneca is seeking partners to develop solutions with digital technology to accelerate clinical trials and improve health outcomes for patients.
-
Acne Drug Shown to Treat Early Multiple Sclerosis
A clinical trial in Canada shows a common and inexpensive antibiotic to treat acne can reduce the chance early-stage multiple sclerosis becomes a full-blown disease.
-
Precision Medicine Trial Shows Reduced Pain, Opioid Use
A large-scale clinical trial tracking pain treatments guided by genetic testing shows large majorities of participants report less pain, with fewer individuals using opioid drugs.